Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
New Strong Sell Stocks for August 15th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
• Abaxis Inc develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. The Zacks Consensus Estimate for its current year earnings has been revised 5.1% downward over the last 30 days.
• Acadia Healthcare Company Inc (ACHC - Free Report) is a provider of behavioral healthcare services. The company operates in two segments: U.S. Facilities and U.K. Facilities. The Zacks Consensus Estimate for its current year earnings has declined 7.2% over the last 30 days.
• Alexion Pharmaceuticals, Inc. a biopharmaceutical company that develops and commercializes life-transforming therapeutic products. It has seen the Zacks Consensus Estimate for its current year earnings being revised 4.7% downward over the last 30 days.
• ArcBest Corp (ARCB - Free Report) is a holding company of businesses providing freight transportation services and logistics solutions. The Zacks Consensus Estimate for its current year earnings has tanked 17.6% over the last 30 days.
• Aviva Plc provides long-term insurance and savings, general and health insurance, and fund management products and services worldwide. The Zacks Consensus Estimate revision for its current year earnings was a negative of 9.8% over the last 30 days.
View the entire Zacks Rank #5 List.